The University of North Carolina at Chapel Hill
| UNC-CH
| UNC-Chapel Hill
  • UNC Calendar
  • Libraries
  • Maps
  • UNC Departments
  • Search UNC
  • Accessibility
Innovate Carolina Logo
  • Our Services
    • Innovation Strategy
    • Design Thinking
    • Impact Measurement and Reporting
    • Investor Programs
    • Online Entrepreneurship Advice
    • Patent Landscaping & Market Research
    • Social Innovation
    • Startup Accelerators and Venture Services
    • Student Innovation Services
    • Technology Commercialization
  • Resources
    • Take A Course
    • Get Funding
    • Start A Venture
    • Find a Workspace
    • Enter a Competition
  • Stories
    • Top News
    • Videos
    • Innovator Insights
    • Newsletter
    • Podcast
  • About
    • Team
    • Vision, Mission & Values
    • Brand
    • Strategy
    • Networks
    • Reports
  • Events
    • Signature Events
    • Event Calendar
  • Impact
    • I&E Impact Dashboard
  • Give
Innovate Carolina Logo

Category: IP & Commercialization

1 2 Next »
aerem-team
  • Economic & Social Impact,
  • IP & Commercialization,
  • Startups & Ventures

Building smarter so we can breathe easier

Innovation is fluid, and the art of tapping into the right resources and support at the right time is crucial,...
duke-unc-venture-day
  • Funding & Investors,
  • IP & Commercialization,
  • Startups & Ventures

Investor’s Corner: UNC and Duke join forces for Virtual Venture Day

On Thursday, November 12, 2020, UNC- and Duke-affiliated startups presented to 66 representatives from top biotech venture capital firms. Hosted...
life-sciences-launch-lab
  • Economic & Social Impact,
  • IP & Commercialization

TBJ: Pandemic driving innovation, commercialization at Triangle universities

Despite Covid-19 causing worry among many in higher education over valuable revenue streams, research universities in the Triangle say their...
denali-dahl-research-lab
  • Innovation & Entrepreneurship,
  • Economic & Social Impact,
  • IP & Commercialization,
  • Startups & Ventures

Innovate Carolina report: UNC-Chapel Hill moves more research discoveries to market

During fiscal years 2019 and 2020, Carolina inventors turned an increasing number of ideas from their labs into inventions, patents,...
Nieto Photography 2015
  • IP & Commercialization,
  • Startups & Ventures

Innovating on inflammation

More than 23 million people in the U.S. suffer from rare and prevalent inflammatory diseases, including Still’s disease, idiopathic pulmonary disease –...
2020-Celebration-of-Inventorship
  • IP & Commercialization

Celebration of Inventorship set for Sept. 10

The UNC Office of Technology Commercialization will host the annual Celebration of Inventorship on Thursday, September 10 at 4:30 p.m....
810_3263
  • Innovation & Entrepreneurship,
  • IP & Commercialization,
  • Startups & Ventures

‘Believe in your ideas and persevere’

science-lab-test-tubes
  • Economic & Social Impact,
  • IP & Commercialization

Pinnacle Hill builds momentum

Finding new therapies and medicines for some of the world’s most perplexing and deadly diseases won’t happen with a same-old,...
0N2A3825-as-Smart-Object-1
  • IP & Commercialization,
  • Startups & Ventures

Precision dose measurement for the smallest patients

As a patient undergoing chemotherapy, the last thing that should be on your mind is if you will receive the...
Mireya
  • IP & Commercialization,
  • Startups & Ventures

From pandemic downturn to startup upswing

Pinnacle Hill Logo Full Color
  • IP & Commercialization

Second project announced through UNC-Deerfield partnership

Finding new therapies and medicines for some of the world’s most perplexing and deadly diseases won’t happen with a same-old,...
810_6577 copy
  • Economic & Social Impact,
  • IP & Commercialization,
  • Startups & Ventures

EmpowerRT: ‘There is a force pushing me’

When Innovate Carolina last caught up with Sha Chang, founder of social enterprise EmpowerRT and professor at the UNC School of Medicine, she was...
nsf-rapid-grand-forest-lai-freeman
  • Innovation & Entrepreneurship,
  • IP & Commercialization

UNC team receives NSF RAPID grant for COVID-19

Carolina researchers focus on the lung-mucus barrier, the first line of defense against inhaled viruses An interdisciplinary team from the...
kickstart-awards-spring-2020
  • Funding & Investors,
  • IP & Commercialization,
  • Startups & Ventures

Four UNC startups win KickStart Commercialization Awards

Epigenos Biosciences, Enfuego Therapeutics, Enzerna Biosciences, and NabGen Inc. receive funding to turn inventions created at UNC-Chapel Hill into transformative...
mireya-mckee-kickstart-accelerator.png
  • IP & Commercialization,
  • Startups & Ventures

Minding the funding gap for startups

An interview with Mireya McKee, KickStart Venture Services How would you describe the need for gap funding/accelerator programs to someone...
ralph baric
  • IP & Commercialization

A material difference

0N2A0053 copy
  • IP & Commercialization,
  • Startups & Ventures

Muting genetic mutations

kickstart-awards-spring-2019-header
  • IP & Commercialization

Pinnacle Hill announces first project agreement

Alliance Between UNC-Chapel Hill and Deerfield intends to advance select Carolina innovations toward a possible new treatment against multiple myeloma...
810_6514
  • IP & Commercialization,
  • Startups & Ventures

Personalized drug delivery in 3D

Rahima Benhabbour has always been an advocate for women’s health issues. As an assistant professor in the UNC/NC State Joint...
kvs-awards-hero
  • Funding & Investors,
  • IP & Commercialization,
  • Startups & Ventures

UNC startups win KickStart awards for airway disease therapies, pediatric AR gaming

Initos Pharmaceuticals and STATApps receive funding to turn inventions created at UNC-Chapel Hill into transformative technologies KickStart Venture Services has...
lab-pfizer-fellows
  • IP & Commercialization

Funding Opportunity: Pinnacle Hill RFP Now Open

$65 Million in Targeted Funding for Drug Development Projects The Pinnacle Hill  RFP opened on September 3rd and will close...
kickstart-awards-spring-2019-header
  • IP & Commercialization,
  • Startups & Ventures

Hope for cystic fibrosis patients

Story by WRAL TechWire Path BioAnalytics (PBA), a precision medicine startup with ties to UNC Chapel Hill, has scored the...
path-bioanalytics
  • IP & Commercialization,
  • Startups & Ventures

Path BioAnalytics announces new license for targeted CF therapy

Read full announcement on Path BioAnalytics site Path BioAnalytics Inc. (PBA), a precision medicine company focused on the discovery and...
810_3622 copy
  • IP & Commercialization,
  • Startups & Ventures

Turning the tables on unhealthy products

UNC public health venture Counter Tools gives communities and policy makers insights to reduce the impact of tobacco and other...
kim-brouwer-lab
  • IP & Commercialization

UNC Inventor of the Year: Kim Brouwer

By Gary Moss, University Gazette Twenty years ago, Kim L. R. Brouwer was a young clinician scientist in Carolina’s School...
810_5508 copy
  • Funding & Investors,
  • IP & Commercialization,
  • Startups & Ventures

Giving the flu his best shot

Emergo CEO Moise Khayrallah cultivates successful pharma and biotech startups and creates opportunities for other promising entrepreneurs The scratchiness in...
bacteria-163711_1280
  • IP & Commercialization,
  • Startups & Ventures

Aiming to be a pioneer in the biopharmaceuticals field

Ward Peterson joined Symberix in late 2013 after realizing that the company had potential to make unprecedented strides in the...
blood-cells
  • IP & Commercialization,
  • Startups & Ventures

Ensuring patient safety

Clinical Sensors, a development-stage biotechnology company based in Research Triangle Park, is developing sensors that can detect and diagnose life-threatening...
Screen Shot 2019-05-03 at 3.33.30 PM
  • IP & Commercialization,
  • Startups & Ventures

Go with your gut

By Jacquelyn Melinek NC Business News Wire Altis Biosystems, a biotechnology company based in Chapel Hill, North Carolina, has developed...
unc-genetics
  • Funding & Investors,
  • IP & Commercialization,
  • Startups & Ventures

AskBio gene therapy company gets $235 million investment

By Jasmin HerreraNC Business News Wire Asklepios BioPharmaceutical Inc., better known as AskBio, has received a $235 million investment to...
1 2 Next »
Innovate Carolina Logo
  • Find us on Linkedin
  • Find us on Facebook
  • Follow us on Twitter
  • Follow us on Instagram
  • Subscribe to our YouTube Channel
109 Church Street, Chapel Hill, NC 27516 | 919.966.3929
© 2021 The University of North Carolina at Chapel Hill